Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eastern Connecticut Hematology & Oncology (ECHO) is an independent community hematology and oncology practice based in Norwich, Connecticut, providing diagnosis, treatment, infusion, supportive care, genetic testing, and access to clinical trials for adult cancer and blood-disorder patients across Eastern Connecticut and nearby Rhode Island. The organization describes itself as a private hematology/oncology practice and emphasizes local, personalized, cost-efficient care outside of larger hospital systems. ECHO offers comprehensive cancer care services, including research participation through cooperative group and industry-sponsored trials, and highlights a long-standing presence in the region of more than 30 years. The practice is affiliated with the ECHO Cancer Foundation, a separate nonprofit that provides supportive services for patients and caregivers. Overall, ECHO is a commercial-stage healthcare delivery organization rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eastern Connecticut Hematology & Oncology.